Gynecologic Oncologist, parent, advocate for patients with Gyn cancer. Opinions are mine not NYU Langone School of Medicine
Joined March 2013
- Tweets1.4K
- Following599
- Followers1.4K
- Likes1K
So proud of my star NP @Kathleen Lutz who is program chair for this meeting! Congrats on a great meeting educating Allied health professionals. @nyulangone @Perlmutter_CC
Day one of the 2026 Allied Health Professionals Meeting is in the books! Attendees gathered to explore advances in gynecologic oncology, share ideas, and strengthen connections across the care team. The day wrapped up with an opening reception and great conversations. #SGOMtg
Bhavana Pothuri retweeted
Screening at 45, colonoscopy and stool-based tests up front, and blood-based tests entering the mix.
Dr. Aasma Shaukat (@AasmaShaukatMD) previews her Emily Couric Lectureship at @AmCollegeGastro 🎥⤵️
Bhavana Pothuri retweeted
Early data on VS-7375, @VerastemOncolog KRASG12D inhibitor in 2nd line and beyond #PancreaticCancer
50% ORR in 2nd line, 35% in 3rd/4th line
6mo OS of 80%
Proceeding with Phase 3 randomized trial in 1st line pancreatic (VS-7375 +EGFRi v VS-7375 + chemo)
investor.verastem.com/news-r…
Bhavana Pothuri retweeted
Out now in Nature Medicine: a health-system-scale cachexia atlas (52K patients) that describes and predicts outcomes, with prospective risk models for lung, colorectal, and prostate cancer. Congrats to @EdReznik for a landmark paper for the field. nature.com/articles/s41591-0…
Yes @avash22 you are spot on for those diagnosed with cancer! More provocative is should general population based #genetictesting be utilized? With NGS costs decreasing this is where the field is heading. We have a pilot study evaluating this- stay tuned.
Bhavana Pothuri retweeted
What are plastics doing to our health?
In a @TEDx talk, Dr. Leonardo Trasande from @nyulangone examines the evidence linking chemicals used in plastics to human health risks—and where science and policy can make a difference.
Watch the full talk ⤵️ youtube.com/watch?v=2pwaWFA4…
Congratulations Catherine! So well deserved! @Perlmutter_CC
Congratulations to Catherine S. Diefenbach, MD, on her greatly deserved promotion to Professor of Medicine. As Director of Hematology Translational Research and Director of the Clinical Lymphoma Program at the Perlmutter Cancer Center, Dr. Diefenbach is dedicated to providing the best possible care for individuals diagnosed with lymphoma — combining cutting-edge, patient-focused, and translational research with personalized clinical care.
#Exceptionalism #Leadership #FacultyAchievement #TranslationalResearch #Lymphoma
Excited for this trial- a novel design with 3 studies in one protocol! Please enroll PSOC parpi progressors- nice efficacy! Data to be presented at ESMO. @GOG @Perlmutter_CC @gyncsm @SHARECancerSupt @SGO_org @ASCOPost @IGCSociety
To access this GOG-3133 FRAmwork-01 Podcast , click links in bio or go to:
GOG Podcast: ow.ly/Iw8K50ZRuhB
GOG YouTube: ow.ly/zpV950ZRuhE
#clinicaltrials #GOGF #GOGPartners #GOGF #ovariancancer #GCAM #IWishIKnew @EliLillyandCo @BPothuri
Bhavana Pothuri retweeted
Did you know? Genetic mutations that increase risk of ovarian, uterine & other cancers can be inherited from either biological parent, fathers as well as mothers. Learn more at bit.ly/4yeO8hE
ALT Image of a woman from our community with her daughter and husband at her daughter's graduation ceremony. OCRA's Ovarian & Gynecologic Cancer Awareness Month badge is at the top of the graphic. Text underneath photo reads: "Men carry and pass on genetic mutations which may increase risk of ovarian, uterine and other cancers for their children. Learn about genetic testing and prevention options. KNOW YOUR RISK. TAKE ACTION. ocrahope.org/ovcamonth"
Bhavana Pothuri retweeted
The latest episode of the GOG’s Accrual Culture series—Top Points for Site Selection—is now live on the GOG Podcast Channel, ow.ly/U9xL50ZQ6jn, and YouTube, ow.ly/Qa3l50ZQ6jo! #GOGF #GOGP #gynecologiconcology #clinicaltrials #GCAM #IWishIKnew
Bhavana Pothuri retweeted
We are excited to partner with @AmericanCancer for the Making Strides Against Breast Cancer walks Manhattan, Long Island, Brooklyn and Staten Island this October!
RSVP to walk with our PCC care teams: i.nyulangone.org/29o
@NYULangone @NYULangoneLI @NYULangoneBK
Bhavana Pothuri retweeted
Congratulations!
@nyulangone Named No. 1 Health System for 5th Consecutive Year by Vizient, making it the first health system to earn a top ranking in this category five years in a row.
prnewswire.com/news-releases…
Bhavana Pothuri retweeted
Proud of our @nyulangone Dean (and prior @Perlmutter_CC Director) Alec Kimmelman for his @Nature paper today:
Hepatocytes promote liver metastasis of #PancreaticCancer by providing serine
nature.com/articles/s41586-0…
With @BarDafna @RichPossemato @KoelinaG @nyugrossman
Bhavana Pothuri retweeted
Two weeks until OLN Great Debates in Solid Tumors arrives in NYC!
Meet some of the local oncology experts joining faculty from across the country to debate the questions shaping solid tumor care.
hmpglobalevents.com/olngreat…
#OLNGreatDebates
This is critical- we need advocacy to ensure increased funding for #endometrialcancer @gyncsm @SHARECancerSupt @ECANAwomen @ASCO @GOG @Perlmutter_CC
The House included $10M for Endometrial Cancer Research in the FY2027 defense appropriations bill but funding needs to make it to the final package. Show lawmakers why endometrial cancer research funding should be priority: sgo.org/news/sgo-launches-en… #FundEndometrialCancerResearch
Bhavana Pothuri retweeted
Targeted therapies are reshaping advanced ovarian cancer care. Learn how to apply the latest evidence on PARP inhibitors, ADCs & emerging regimens with Drs. Bhavana Pothuri (@Bpothuri) & Premal Thaker: bit.ly/4buMQpH
Partnered with @NOCCNational
#OvarianCancer #SGO2026
Bhavana Pothuri retweeted
🔬 Four-year follow-up from the RUBY trial adds to the growing evidence supporting frontline immunotherapy in endometrial cancer!
Patients with dMMR/MSI-H primary advanced or recurrent disease continued to demonstrate durable benefit with dostarlimab + carboplatin/paclitaxel, reinforcing this regimen as a key treatment option.
#GynOnc #EndometrialCancer #SGO #Immunotherapy
Check it out here: tinyurl.com/35s7wayc
Bhavana Pothuri retweeted
This #GCAM, let's turn awareness into action. From improving referral pathways to supporting advocacy efforts, we all have a role in making high-quality gynecologic cancer care more accessible. Read the blog: sgo.org/blog/from-awareness-… #GynOnc
Bhavana Pothuri retweeted
🎙️ New listen: Updates in FDA Approvals for PARP Inhibitors in Ovarian Cancer. A clinical practice review, now available as a podcast from Gynecologic Oncology.
The panel unpacks how the PARPi approval landscape has shifted in ovarian cancer. This is essential listening for anyone making maintenance therapy decisions in clinic.
🎧 Listen via the journal's homepage: tinyurl.com/4w99scf7
#GynOnc #OvarianCancer #PARPinhibitors #SGO #OncologyEducation
Bhavana Pothuri retweeted
📅 Applications for the LEAD Program close July 20! Invest in your future with a program focused on leadership development, mentorship, networking and professional growth in #GynecologicOncology. If you've been thinking about applying, now is the time. 🔗 ow.ly/hq6p50ZoVS4